Ballentine Partners, LLC Pfizer Inc Transaction History

Ballentine Partners, LLC

$5.81 Billion
Q3 2024

A detailed history of Ballentine Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ballentine Partners, LLC holds 108,861 shares of PFE stock, worth $2.87 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

108,861

Previous 107,689 1.09%

Holding current value

$2.87 Million

Previous $3.01 Million 4.55%

% of portfolio

0.05%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$27.7 - $31.39 $32,464 - $36,789	1,172 Added 1.09%	108,861 $3.15 Million
Q2 2024 Aug 06, 2024	SELL	$25.26 - $29.6 $183,766 - $215,340	-7,275 Reduced 6.33%	107,689 $3.01 Million
Q1 2024 Apr 11, 2024	BUY	$25.89 - $29.73 $740,169 - $849,950	28,589 Added 33.1%	114,964 $3.19 Million
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $377,160 - $489,889	-14,434 Reduced 14.32%	86,375 $2.49 Million
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $204,413 - $238,938	-6,370 Reduced 5.94%	100,809 $3.34 Million
Q2 2023 Jul 26, 2023	BUY	$36.12 - $41.79 $933,232 - $1.08 Million	25,837 Added 31.76%	107,179 $3.93 Million
Q1 2023 Apr 27, 2023	SELL	$39.39 - $51.28 $901,558 - $1.17 Million	-22,888 Reduced 21.96%	81,342 $3.32 Million
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $358,757 - $468,318	8,593 Added 8.99%	104,230 $0
Q3 2022 Oct 26, 2022	BUY	$43.76 - $53.42 $158,454 - $193,433	3,621 Added 3.94%	95,637 $4.19 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $129,074 - $153,041	2,774 Added 3.11%	92,016 $4.82 Million
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $33,580 - $41,610	-734 Reduced 0.82%	89,242 $4.62 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $469,808 - $696,412	-11,370 Reduced 11.22%	89,976 $5.31 Million
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $52,909 - $67,966	-1,348 Reduced 1.31%	101,346 $4.36 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $9,480 - $10,739	264 Added 0.26%	102,694 $4.02 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $535 - $604	-16 Reduced 0.02%	102,430 $3.71 Million
Q4 2020 Jan 25, 2021	SELL	$33.47 - $42.56 $117,948 - $149,981	-3,524 Reduced 3.33%	102,446 $3.77 Million
Q3 2020 Oct 22, 2020	SELL	$31.75 - $37.25 $499,713 - $586,277	-15,739 Reduced 12.93%	105,970 $3.89 Million
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $395,897 - $480,281	-13,144 Reduced 9.75%	121,709 $3.98 Million
Q1 2020 Apr 23, 2020	SELL	$27.03 - $38.62 $772,436 - $1.1 Million	-28,577 Reduced 17.49%	134,853 $4.4 Million
Q4 2019 Jan 22, 2020	SELL	$32.92 - $37.36 $176,615 - $200,436	-5,365 Reduced 3.18%	163,430 $6.4 Million
Q3 2019 Oct 21, 2019	SELL	$32.49 - $42.13 $96,560 - $125,210	-2,972 Reduced 1.73%	168,795 $6.07 Million
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $4.04 Million - $4.53 Million	109,182 Added 174.45%	171,767 $7.44 Million
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $138,975 - $152,687	-3,706 Reduced 5.59%	62,585 $2.66 Million
Q4 2018 Feb 04, 2019	BUY	$38.47 - $43.86 $31,353 - $35,745	815 Added 1.24%	66,291 $2.89 Million
Q3 2018 Oct 30, 2018	BUY	$34.47 - $41.81 $17,889 - $21,699	519 Added 0.8%	65,476 $2.89 Million
Q2 2018 Jul 19, 2018	BUY	$32.98 - $35.16 $335,703 - $357,893	10,179 Added 18.58%	64,957 $2.36 Million
Q1 2018 Apr 26, 2018	SELL	$31.91 - $37.02 $175,377 - $203,461	-5,496 Reduced 9.12%	54,778 $1.95 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $11,541 - $12,245	-347 Reduced 0.57%	60,274 $2.18 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $1.88 Million - $2.07 Million	60,621	60,621 $2.16 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Account

Ballentine Partners, LLC Pfizer Inc Transaction History